GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 206 filers reported holding GENMAB A/S in Q2 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,495,651 | -7.2% | 212,522 | +0.0% | 0.00% | 0.0% |
| Q2 2023 | $8,077,733 | +5.3% | 212,516 | +4.6% | 0.00% | 0.0% |
| Q1 2023 | $7,668,074 | -33.3% | 203,074 | -25.1% | 0.00% | -33.3% |
| Q4 2022 | $11,491,167 | +35.7% | 271,146 | +2.9% | 0.00% | 0.0% |
| Q3 2022 | $8,466,000 | -1.2% | 263,488 | -0.1% | 0.00% | 0.0% |
| Q2 2022 | $8,567,000 | -22.8% | 263,670 | -14.0% | 0.00% | 0.0% |
| Q1 2022 | $11,090,000 | -20.2% | 306,524 | -12.7% | 0.00% | 0.0% |
| Q4 2021 | $13,897,000 | -9.5% | 351,280 | +0.0% | 0.00% | -25.0% |
| Q3 2021 | $15,350,000 | +9.0% | 351,272 | +1.9% | 0.00% | +33.3% |
| Q2 2021 | $14,079,000 | -4.5% | 344,823 | -23.2% | 0.00% | -25.0% |
| Q1 2021 | $14,739,000 | +29.4% | 448,937 | +60.3% | 0.00% | +33.3% |
| Q4 2020 | $11,386,000 | – | 280,027 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
| Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
| HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
| Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
| Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
| TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
| First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
| Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
| Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |